| Names | |
|---|---|
| Preferred IUPAC name | 1-(4-Ethoxyphenyl)-3-oxobutan-1-imine |
| Other names | Acetoacetanilide, p-phenetidide Acetoacetic acid p-phenetidide 4-Ethoxyacetanilide N-(4-Ethoxyphenyl)-3-oxobutanamide |
| Pronunciation | /əˌsiːtoʊˈæsɛt piː fiːˈniːtɪdaɪd/ |
| Identifiers | |
| CAS Number | 102-28-3 |
| Beilstein Reference | 1364101 |
| ChEBI | CHEBI:2849 |
| ChEMBL | CHEMBL1255752 |
| ChemSpider | 150418 |
| DrugBank | DB13667 |
| ECHA InfoCard | ECHA InfoCard: 100.007.335 |
| EC Number | 213-167-6 |
| Gmelin Reference | 84755 |
| KEGG | C08445 |
| MeSH | D000177 |
| PubChem CID | 20892493 |
| RTECS number | AM4375000 |
| UNII | Z5VQ1DJ7FJ |
| UN number | 2811 |
| CompTox Dashboard (EPA) | DTXSID8014265 |
| Properties | |
| Chemical formula | C12H15NO2 |
| Molar mass | 293.34 g/mol |
| Appearance | White crystals |
| Odor | Odorless |
| Density | 1.129 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 1.83 |
| Acidity (pKa) | 13.13 |
| Basicity (pKb) | 6.39 |
| Magnetic susceptibility (χ) | -54.0e-6 cm³/mol |
| Refractive index (nD) | 1.5630 |
| Viscosity | Viscous liquid |
| Dipole moment | 4.71 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 420.51 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | −730.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3222.7 kJ/mol |
| Pharmacology | |
| ATC code | N02BA05 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS02, GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | Keep away from heat, sparks, open flames, hot surfaces. No smoking. Wear protective gloves, protective clothing, eye protection, face protection. Wash thoroughly after handling. Avoid release to the environment. |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | Flash point: 113.9°C |
| Autoignition temperature | 355°C |
| Lethal dose or concentration | LD50 oral rat 890 mg/kg |
| LD50 (median dose) | LD50 (median dose): 480 mg/kg (intraperitoneal, mouse) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.5 mg/m3 |
| Related compounds | |
| Related compounds | Ethoxyquin Acetoacetanilide Acetoacet-o-toluidide Acetoacet-m-toluidide Acetoacet-m-xylidide Acetoacet-2,5-dimethoxyanilide |
| Property | Manufacturer Commentary |
|---|---|
| Product Name | Acetoacet-p-phenetidide |
| IUPAC Name | N-(4-ethoxyphenyl)-3-oxobutanamide With technical evaluation, the IUPAC name reflects direct structural substitution on the phenyl ring with an ethoxy group, critical for quality control traceability in analytical characterization steps. |
| Chemical Formula | C12H15NO3 Actual formula is internally referenced in both raw material qualification and downstream batch release checks. Verification uses NMR and elemental analysis per batch for process consistency. |
| Synonyms & Trade Names | 4'-Ethoxyacetoacetanilide, p-Phenetidine acetoacetanilide Industrial usage prefers the shortest name on drum labeling; documentation for customs or export purposes always cross-references synonyms to minimize clearance delays. |
| HS Code & Customs Classification | 2924.29 (for acyclic amides and derivatives) HS code allocations follow the harmonized system for amides with industrial uses. Customs brokers request both full chemical name and code to track permitted use and taxation; process-specific documentation varies according to export destination. |
Raw materials are sourced based on supply chain audit trails and targeted impurity profiles. Suppliers must pass QC evaluation: primary focus remains on 4-ethoxyaniline and acetoacetic ester, as their trace contaminants directly impact final product hue and stability, measured during in-process spectrophotometric monitoring.
Route selection reflects customer application. For pigment intermediate grades, process temperature and pH hold points are set to minimize by-product formation. Routes involving direct condensation enable shorter cycle times but demand tighter control of dehydration conditions to avoid over-alkylation.
Operational checkpoints monitor conversion by HPLC and TLC methods. Each stage includes batch-to-batch traceability records to flag deviations before post-reaction workup. Impurities coming from raw feedstock are routinely reduced by additional pre-treatment filtration steps; any failed intermediate is diverted for off-spec reworking.
Impurity removal uses liquid-liquid extraction coupled with vacuum distillation or recrystallization, selected based on downstream specification. Grades demanded by pharmaceuticals use multi-stage purification; industrial grades often finish by single-cut distillation. Each batch passes UV-Vis and chromatography to meet release criteria, which adjust depending on contractual specification.
Acetoacet-p-phenetidide enters international markets under HS 2924.29. Manufacturers receive periodic requests from regulatory and customs authorities for detailed breakdowns of process impurities and uses, especially where toxicological profiles are subject to changing national guidelines.
Acetoacet-p-phenetidide typically appears as a crystalline or powdery solid, with color and particle morphology varying according to synthesis route and any post-crystallization finishing steps. In most production settings, color tones shift from pale yellow to beige due to trace process-related chromophores. Melting point ranges are batch-dependent and closely tracked as part of the product release criteria; off-spec melting behavior may indicate impurity drift or incomplete purification. Odor is generally faint and aromatic—abnormal or pungent odors generally point to side-process carryover or packaging faults. Boiling point and flash point measurements, seldom practical for this class of compound in daily operations, are generally cited from published references and sometimes verified for regulatory compliance. Density is grade-sensitive and influenced by residual solvent content, compression, or granule sizing steps, so sampling for bulk handling is usually specified by the customer application.
Stability depends heavily on moisture control and storage vessel integrity. Reactivity with acids or strong bases in formulation streams must be taken into account by technical teams when supporting downstream process customers. Handling experience under diverse storage conditions shows sensitivity to hydrolysis and oxidation if exposed to open air for extended periods, especially at scale and in unlined drums. We advise specific analysis of solution stability before formulation or mixing with other actives.
Solubility profiles are application-driven and grade-specific, varying by solvent polarity and the presence of formulation additives. Aqueous solubility is limited under neutral pH, though certain cosolvency systems improve dissolution. During scale-up, solution preparation frequently calls for controlled agitation, pH monitoring, and solvent selection according to end-use requirements. Slurry or suspension forms require careful control to avoid localized precipitation or agglomeration during mixing stages.
Specifications are tailored to customer application and regional requirements. Technical, analytical, and pharmaceutical-intermediate grades may each carry their own profile with distinct assay, impurity, and moisture limits. All key specifications, including appearance, assay (by HPLC or titrimetry), melting point range, and trace impurity maxima, are set internally based on batch data history and controlled in accordance with contractual agreements or market segment standards.
Predominant impurities arise from incomplete reaction, residual starting material, and breakdown products formed during thermal steps or drying. Analytical review focuses on both process- and handling-derived impurities. Downstream customers in regulated markets often request confirmation of compliance with their proprietary impurity acceptance criteria and residual solvent standards. The impurity profile is directly influenced by process configuration and raw material quality, so supplier change control and routine analytical trending play a key role.
Routine analysis may involve HPLC, GC, IR spectroscopy, and titrimetric determination. Methods are validated in-house, but reference procedures may be incorporated upon mutual agreement with key clients. Product release hinges on complete analytical batch records and, where relevant, COA verification against client technical files.
Selection of ethyl acetoacetate and p-phenetidine as starting materials is determined by cost, availability, and required purity for the target grade. Procurement focuses on consistency of supply and minimization of trace contaminants that might carry through to the final product or complicate purification.
The principal synthesis proceeds via condensation under controlled temperature and catalyst guidance. Route choice reflects downstream impurity burden, raw material cost structure, and environmental compliance. Strictly controlled reaction conditions help avoid side reactions, especially at scale.
Critical parameters during reaction include time, temperature, pH, and agitation speed. In-process testing addresses intermediate purity, impurity drift, and color development. Subsequent purification—typically via recrystallization or solvent wash—mitigates byproduct inclusion and ensures end-use acceptability. Each batch follows pre-defined control charts and may be reworked if deviation from norms is identified at intermediate checkpoints.
Batches are released only after full specification compliance is demonstrated across assay, physical appearance, impurity profile, and solution test results. Data is archived and reviewed for both client-facing documentation and regulatory audit preparedness.
Acetoacet-p-phenetidide reacts as a nucleophile and can participate in further condensation or coupling reactions in the presence of base or acid catalysts. Downstream chemical modifications that utilize the acetoacetyl group often require closely managed pH and temperature windows to avoid product breakdown or uncontrolled oligomerization.
Typical synthetic transformations apply solvent systems tailored for the intended downstream product. Catalyst selection is heavily influenced by desired reaction speed and impurity suppression. Thermal management and controlled addition are employed to avoid exothermic runaway or discoloration.
This compound serves as a key intermediate for specialty dyes, pharmaceuticals, and fine chemicals. Empirical compatibility tests support project-specific downstream synthesis requests. Modification potential often depends on both the technical grade supplied and any client-imposed impurity restrictions.
Storage guidance reflects sensitivity to moisture, oxygen, and excessive light. Best operational practice involves sealed, inerted containers, stored in cool, shaded warehouses with humidity and temperature logging. Warm or damp storage environments accelerate degradation, commonly tracked by color shift and loss of assay.
Compatibility trials suggest preference for high-density polyethylene or lined steel drums; unlined metal increases risk of product-metal interaction and color development. Long-term storage in glass is not employed at industrial scale due to handling risk and breakage.
Shelf life is grade-dependent and application-driven. Manufacturers rely on analytical trending; evidence of expiration includes appearance changes, assay drop, and off-odor formation. Each batch may be re-tested if stored longer than six months, with reprocessing or disposal guided by stability data and external regulations.
GHS classification depends on regional regulatory frameworks and the exact impurity profile. Manufacturers advise all users to consult the latest SDS for their own regulatory jurisdiction and specific product grade.
Hazards typically relate to acute toxicity, skin/eye irritation, and potential hazardous decomposition products in case of fire. Standard precautions involve use of gloves, goggles, and localized exhaust ventilation during handling. Emergency guidance relies on established toxicological data and operational training.
Toxicological profile is under constant review as new reference studies emerge. Batch trace contaminants may shift the observed response in acute and chronic exposure studies, so manufacturers manage through specification control and technical dialogue with customers.
Exposure recommendations reference both internal industrial hygiene monitoring and external chemical safety guidelines. Dust suppression, careful weighing, and mechanical containment limit personnel risk. Ongoing training in spill containment and first-aid response forms part of mandatory safety programs at the production plant.
Our production lines for Acetoacet-p-phenetidide operate on a batch synthesis model to balance cost and stable output levels. Batch scheduling depends on demand from pharmaceutical, dye intermediate, and specialty chemical sectors. Any shift in regulatory approvals, major projects, or raw material supply chain constraints can disrupt routine capacity planning. Typical batch turnaround, including in-process testing and purification, may be adjusted to meet grade-specific contamination profiles or impurity limits. Output rates generally fluctuate seasonally, particularly based on the upstream acetoacetate and aniline derivative market situation.
Standard lead times stem from both batch scheduling and the route clearance for the required grade. Lead times are shortest when the requested grade matches the routinely produced specification, subject to current stock and prior allocations. MOQ often aligns with reactor output, filling system constraints, and logistics efficiency. MOQs increase with custom certification requirements, multi-stage purification, or unique packaging formats.
Packaging selection takes into account customer handling infrastructure, required purity control during transit, and regulatory needs. Options range from lined fiber drums to stainless steel intermediate bulk containers, with each selected for chemical compatibility, manipulation convenience, and contamination control. Pre-shipment batch release is tied to the packaging format validation for both material safety and regulatory conformance.
Shipping practices favor cost-effective bulk freight for sizable industrial orders and specialized carriers for smaller, higher-grade consignments. Temperature and moisture controls are implemented according to grade sensitivity and regional climate impacts. Payment terms reflect customer history, size of commitment, and balance sheet credibility, with custom arrangements subject to financial controls.
Major cost drivers include acetoacetic ester derivatives, phenetidine, catalyst systems, and solvent cycles. Feedstock source stability and purity requirements lead the direct variable cost calculation. Sourcing anomalies or regulatory escalation on precursor chemicals, particularly environmental levies or restrictions in core production geographies, can skew input prices and impact batch cost consistency. Energy input remains a variable factor under international fuel and utility price movements.
Raw material price volatility traces back to global disruptions in benzene chain intermediates, seasonal shifts in crop-based precursors, and geopolitical shifts affecting major producer countries. Catalysts and specialty solvents, being less standardized, respond acutely to changes in national import regimes and incident-driven shortages. Regulatory compliance costs, especially for higher-purity or restricted-use grades, further influence per-batch production cost variances.
Price differentials reflect required grade (e.g., technical, pharma, or customized), purity spectrum, post-synthesis refinement steps, and alignment with country-specific packaging or certification mandates. Documentation burden—such as full traceability and REACH/US FDA/JP PMDA registration—translates into higher quoted prices. Packaging complying with ADR or UN standards commands a premium due to validation and segregation costs.
Demand strength clusters in pharmaceutical intermediates, specialty pigments, and agricultural chemical applications, governed by synthesis demand cadence rather than pure commodity cycles. Availability tightens notably during rapid expansions of regulatory regimes or rollouts of new API manufacturing projects, particularly in Asia and selected European countries. Import surcharges and port congestion can exacerbate short-term tightness, especially for grades sensitive to transit conditions.
Price direction will likely trend upwards, anchored by expected environmental compliance escalation in major producing countries, energy cost risk, and the growth in regulated end-use markets. Market stabilization efforts through contract manufacturing arrangements could blunt extreme volatility but are unlikely to reverse the upward cost pressures linked to feedstock tightening and regulatory harmonization.
Commentary relies upon internal production benchmarking, real-time upstream feedstock purchasing records, sectoral regulatory briefings, import-export shipment analytics, and quarterly market intelligence reviews.
Rising intensity in regulatory scrutiny, notably among APAC and EU producers, is reshaping the supply chain. Accelerated compliance with environmental, health, and product stewardship regulations span raw material sourcing to in-plant emissions, affecting both operating costs and production predictability.
Key updates focus on expanded precursor chemical tracking and mandatory grade-level reporting. Implementation of new environmental management standards in higher-output zones (notably in China and India) is pending, with potential impact on both permitted production volume and inventory logistics. Enforcement of new transport certification standards in Europe and the US is increasing operational costs for downstream packaging and shipping.
Our process management continually adapts through route re-optimization, vertical integration where possible, and strategic inventory buildup in anticipation of regulatory-induced batch disruption. Engagement with third-party auditors and certification programs is prioritized to ensure ongoing eligibility for export to regulated markets, particularly in pharma-driven applications.
Production teams in dye intermediates, pigment manufacturing, and select pharmaceutical synthesis rely on acetoacet-p-phenetidide for its specific reactivity and compatibility profiles. In dye synthesis, it serves as a coupling component during azo dye production, where purity and color-shade stability are major priorities. In pigment formulations, consistent particle morphology and impurity patterns play a direct role in final dispersion quality. Pharmaceutical labs and intermediate producers may source custom grades for exploratory synthetic steps, focusing sharply on controlled impurity content and batch-to-batch consistency.
| Application | Typical Grades Used | Critical Selection Factors |
|---|---|---|
| Azo Dye Manufacturing | Industrial dye-grade, custom high-purity | Shade consistency, trace metals, color strength |
| Pigment Intermediates | Technical, standard industrial | Residual solvents, particle control, batch uniformity |
| Pharmaceutical Research | Analytical/Custom high purity | Defined impurity limits, documentation, regulatory traceability |
Process lines request grades with different specifications based on downstream compatibility. Color-matching labs often flag trace metal content and byproduct chromophores as rejection points. Paint and pigment processors check for particle size consistency (where the crude or milled grade is used directly), and reject batches showing excessive agglomeration, which traces back to raw material moisture or incomplete reaction. For regulated pharma steps, buyers may request full impurity profiling and validated analytical methods for each lot.
Moisture content, solvent residuals, and bulk density show strong dependence on both synthesis route and final processing (spray-dried versus naturally crystallized). Grades intended for blending must provide a specification for sieve fraction and flowability. Where downstream operations call for large batch blending, flow behavior and agglomeration tendency are essential to avoid line blockages or inconsistent dosing.
Production lines that specify acetoacet-p-phenetidide for dyes, pigments, or intermediates start with intended end-use. If finished product purity or color matching forms the critical endpoint, define this first as it sets the bar for all other grade choices.
Users operating under regulatory oversight, including pharma intermediates and food-contact pigments, must reference local or export-market rules. Not all grades originate from GMP-controlled environments or include impurity profiling to pharmaceutical standards. Clarify the required compliance profile before sampling or ordering bulk lots.
Industrial users commonly request minimum assay figures and impurity cutoffs. Where the process is color or reactivity sensitive, set tighter acceptance ranges for byproducts and trace contaminants. Open technical channels with the QC department for documentation on batch analysis and lot traceability.
Batch size and delivery schedule pressure the producer’s line scheduling and choice of purification intensity. For high-throughput users (such as base dye plants), tolerance for minor off-specification lots can lower cost. R&D groups and validation labs require short runs and sample-scale packaging, with a premium on rapid switch-over and documentation flexibility.
After clarifying specifications with technical teams, request representative samples for pilot-scale validation. Analytical and process departments compare physical and chemical properties against internal benchmarks to confirm suitability. Bespoke requirements, including impurity targeting, alternate solvents, or special particle grades, receive custom test protocols prior to main production. Customer validation provides the last filter before large-scale commitment.
Continuous, transparent quality management forms the foundation of our production. Sites engaged in the production of Acetoacet-p-phenetidide operate under formalized quality management systems, such as ISO 9001, with regular on-site audits, process mapping, and traceability at each stage of synthesis and downstream processing. Incoming raw materials undergo batch-wise identity verification and risk assessment on potential critical impurities originating from manufacturing routes or upstream suppliers. Each release batch is handled with a defined review workflow, ensuring full record traceability.
Certification for each Acetoacet-p-phenetidide batch includes an internal Certificate of Analysis, which reports test results against grade-dependent or application-specific acceptance criteria. For customers in regulated segments seeking REACH registration or compliance with particular chemical control frameworks, supporting test documentation and regulatory outcome statements are issued upon request. Halal, Kosher, or other product-specific compliance support can be addressed if required for the intended end use and market.
Release documentation includes batch CoA, detailed test reports, stability test findings (where requested), and, for industrial customers, GMP or ISO certification evidence. Upon customer request, we share typical regulatory filings, Safety Data Sheets harmonized to GHS and local formats, and track record data of retained batch samples. Stability and impurity data may be included if required by the customer’s downstream process validation.
Industrial manufacturing demands steady capacity planning. Our production lines are designed for mid- to large-scale output scenarios, with documented annual capacity and batch scheduling. We support both contract-based off-take and seasonal procurement. Emergencies or market volatility receive fast priority scheduling; multi-year framework agreements allow for capacity reservation to align with long-term project requirements.
Manufacturing reliability starts with careful feedstock sourcing and alternate supplier qualification for all key intermediates. Process bottlenecks are identified during scale-up trials and addressed by dedicated redundancy strategies, including parallel reactor trains for critical stages and in-house recovery and recycling of solvents whenever feasible. Batch-to-batch consistency is tracked using statistically sampled analytical markers, and intermediate storage tanks remain segregated by production run to avoid cross-contamination. Outcomes of in-process controls dictate real-time adjustments to heating, solvent changeover, or neutralization to maintain output within defined release limits.
Sample requests are individually assessed based on intended use, volume, and technical requirements. Technical documentation accompanies all evaluation samples, including grade declaration, analytical report, and storage recommendations. Priority is given to bulk consumers qualifying pre-shipment or multi-lot supply, but small-volume R&D partners also receive attention with matched documentation. All outgoing material for sampling is traceable to its batch manufacturing record.
The cooperation model adapts to sourcing and project needs: fixed-quantity monthly dispatch, forecast-driven quarterly replenishment, or consignment at dedicated offsite warehousing for just-in-time drawdown. Custom packaging, palletizing, or specific logistic instructions are executed as per alignment with downstream processing requirements, and dedicated supply chains can be established for customers needing integration into continuity-sensitive operations. Technical stakeholders at both ends are connected directly to expedite documentation, query resolution, and change management in response to evolving product or regulatory requirements.
From a production standpoint, attention focuses on optimizing synthetic routes for acetoacet-p-phenetidide in alignment with availability and purity of raw materials such as p-phenetidine and diketene. Facilities constantly assess reaction conditions and catalyst alternatives, with R&D teams working on reducing process impurities. Analytical chemists monitor minor contaminants like residual ketone or amine species, as these affect downstream purity and color stability. In the practical manufacturing environment, controlling moisture levels is a recurring challenge due to acetoacetate hydrolysis sensitivity. Both laboratory and pilot-scale batches are monitored for polymorphic transitions and handling characteristics to support different downstream user requirements in dyes and pharmaceutical intermediates.
Technical studies have documented increasing niche adoption in specialized pigment and pharmaceutical intermediate syntheses, with formulators trialing acetoacet-p-phenetidide in new heterocycle coupling routes. The R&D community discusses modifications for enhanced reactivity or selectivity in Friedel-Crafts or condensation reactions. Some customers demand customized particle morphology or purity profiles to fit equipment needs in continuous flow setups instead of conventional batch reactors.
Industrial batch reproducibility remains tied to raw material lot variability and the delicate balance of reaction temperature, catalyst load, and solvent retention strategy. Heat-sensitive intermediates introduce scale-up risks and drive efforts to implement in-line analytics for real-time adjustment during production. Recent process improvements focus on automated sampling for impurity tracking and closed-system handling to protect sensitive lots from atmospheric contamination. Such approaches have reduced persistent off-color and minimized post-reaction rectification requirements.
Over the next three to five years, the market outlook is shaped by stable demand in colorant manufacture and selective pharmaceutical segments. Regulatory focus on impurity profiles in finished products prompts facilities to strengthen process control protocols. Growth rates remain dependent on regional end-user legislation, particularly in Europe and East Asia, and on upstream raw material reliability. Flexible facility design and toll manufacturing partnerships are expected to play a larger role in ensuring uninterrupted supply chains.
Production trends point toward semi-continuous feeding systems and real-time product segregation based on in-process analytics. These advances allow for closely graded batches tailored to individual client reactivity or solubility needs. Investments in digital process monitoring limit batch-to-batch deviations and improve impurity clearance, supporting pharmaceutical-grade supply. Development teams prioritize eco-friendly solvent recovery and energy integration initiatives where feasible, especially as solvent handling regulations grow stricter globally.
Process optimization draws on green chemistry principles, especially in waste minimization and solvent recycling strategies. Raw material selection considers both cost and lifecycle impact. Projects targeting aqueous or less hazardous solvent platforms have reduced worker exposure and simplified post-reaction effluent handling in newer reactors. Opportunities for circular process water use are under review to achieve both emissions reductions and cost efficiency. Supplier audits ensure incoming materials adhere to required sustainability criteria.
Direct manufacturer support includes in-depth review of technical requirements, from compatibility in pilot trial runs to troubleshooting batch inconsistencies. Customers may request tailored advice regarding filtration, crystallization, or drying steps, especially where custom purity or particle size specifications apply. Support teams coordinate with R&D to interpret analytical results and recommend possible process adjustments.
Customers pursuing new application areas, such as non-traditional pigment dispersions or pharmaceutical intermediates, can engage process engineers to test sample adaptions of acetoacet-p-phenetidide. Feedback loops with users help define optimal dissolving protocols or point out issues with intermediate stability during storage or transfer, which is handled collaboratively between customer QA/QC and manufacturer technical staff.
Technical personnel provide ongoing batch tracking and issue resolution. Support extends to documentation for regulatory submissions and product registration, which often require detailed impurity and characterization data specific to supplied lots. Changes in process, equipment, or raw material sourcing are communicated proactively to clients, and adaptation guidance is provided for formulation consistency across supply batches. This approach ensures downstream users receive actionable support based on the realities of large-scale chemical production and distribution.
As a factory directly engaged in the synthesis and supply of Acetoacet-p-phenetidide, transparency and manufacturing integrity guide our operations. Our facilities handle every stage of production, from raw material intake to finished packaging. The manufacturing process relies on batch controls, automated monitoring, and a traceable quality system designed to maintain stable outputs across each lot.
Industrial end users in dyes, pigments, and specialty chemical synthesis primarily drive demand. Many colorant manufacturers depend on controlled acetoacet-p-phenetidide for coupler formation, particularly where shade reproducibility determines marketability. In pharmaceutical intermediates, the same compound plays a key part in multi-step syntheses requiring clean starting material and tight impurity profiles. Lab reagent producers call out for analytical consistency, favoring full material traceability from a single production origin.
Our quality control lab runs in parallel with production, not as an afterthought. Each lot undergoes analysis through spectroscopic and chromatographic methods. Sampling protocols are documented and standardized; the final product must align with set identity and purity ranges before movement into finished goods storage. By running periodic equipment calibrations and chemical audits, we reduce batch-to-batch variance.
Production volume adapts to project and ongoing contract requirements, with regular capacity expansions based on demand forecasting rather than opportunistic speculation. We offer drum, bag, and lined bulk packaging under controlled conditions to meet transport and storage standards for chemical processors. Lots can be palletized and labeled per export norms or tailored for high-throughput operations.
Direct communication with our technical staff shortens troubleshooting cycles for process engineers and R&D teams. Whether optimizing feedstock ratios in dye plants or clarifying solubility during formulation scale-up, industrial buyers receive dedicated application advice. Specifications extend beyond paperwork to in-house method validation and plant visit support for partners managing critical syntheses.
Manufacturers and procurement managers working with our plant benefit from open production timelines and material consistency, not opaque reselling networks. Cost forecasting stabilizes with direct scheduling and full lot transparency. Distributors handling bulk supply gain logistics reliability stemming from our hands-on coordination, minimizing handling delays and miscommunication across supply stages.
| Manufacturing Benefit | Customer Value |
|---|---|
| Controlled lot release | Predictable reactivity for downstream processes |
| Direct process oversight | Reduced sourcing risk, lower requalification costs |
| Technical support at the manufacturing level | Improved process integration and fewer troubleshooting delays |
| Flexible packaging and logistics | Alignment with warehouse and plant handling systems |
Factories seeking greater confidence in their procurement can count on a proven, traceable source of Acetoacet-p-phenetidide, supported by comprehensive technical resources and direct accountability for supply performance.
In chemical manufacturing, purity always remains non-negotiable, especially for compounds like Acetoacet-p-phenetidide. Our production team is familiar with the expectations from pharmaceutical and specialty chemical sectors, where even trace impurities can impact downstream performance or regulatory approvals. We routinely see requests for material with over 99% purity, recognizing the need for reproducibility batch after batch. Achieving this level of cleanliness doesn’t come from luck; it comes from fine-tuning every stage of synthesis, filtration, and drying. Raw input material plays just as large a role as the processing conditions, so we invest in primary feedstock quality and in-line testing from the outset.
Our product, Acetoacet-p-phenetidide, is a specific organic compound with a well-defined molecular structure. Structurally, it features the acetoacetyl moiety attached to a para-phenetidine base. To put that into perspective, the backbone of the molecule consists of an ethoxy group (–OCH2CH3) at the 4-position of the aniline ring, with the acetoacetyl substituent bonded through the amide linkage. The molecular formula reads C12H15NO3 and the central arrangement determines the product’s chemical behavior in applications ranging from pigment synthesis to pharmaceutical intermediates.
Our quality control team uses NMR spectroscopy, HPLC, and IR analysis to validate molecular integrity and screen for common contaminants. This attention to analytical transparency forms the backbone of our compliance, letting customers integrate our Acetoacet-p-phenetidide into their formulations without second guessing the material’s composition.
Customers regularly ask about how we guarantee such high levels of purity. The answer rests in our reaction setup and post-reaction handling. In our plant, crude product undergoes multiple purification steps—usually recrystallization or column chromatography, depending on the batch size and end application. We monitor every step with close analytical oversight. Even trace solvents and process-related byproducts must stay below strict thresholds set by internal and customer-driven specifications.
We store finished Acetoacet-p-phenetidide under dry and controlled conditions because moisture, even ambient humidity, can impact long-term stability. Each drum or package receives a unique batch number and full quality document packet tracking the complete production and analysis trail.
Our labs never stay static. We continue to improve not only the chemical purity but also the efficiency of each step, aiming for both sustainability and uncompromised product standards. Customers sometimes request bespoke purities or formats, and our technical team can advise on feasible modifications within the capabilities of our plant. As new applications for Acetoacet-p-phenetidide emerge, we adapt our procedures to support both traditional and innovative uses. We routinely share updates with partners as methods evolve, validating each change with in-house and third-party data.
Our direct production and hands-on approach allow us to stay close to the material at every stage. We welcome technical discussions around expected purity, impurity profiles, and the physical characteristics that matter for end-use. Customers can always count on our transparency, consistency, and willingness to push process development forward, backed by decades of manufacturing experience.
Producing Acetoacet-p-phenetidide demands careful scheduling, precise batch management, and a clear understanding of downstream application requirements. Any discussion around minimum order quantity (MOQ) and lead time ties directly to our experience running dedicated synthesis lines and maintaining compliance across quality and safety standards.
MOQ isn’t just a number set for bookkeeping convenience. Each production run for Acetoacet-p-phenetidide involves fixed costs—setup, cleanup, raw material weigh-in, environmental controls, and comprehensive QC testing. Process reactors require a practical minimum fill to ensure both yield and reactor safety. Based on these realities, our MOQ reflects both process efficiency and financial practicality. For standard scheduling, we set the MOQ at the batch scale that keeps raw material use optimal, minimizes loss, and lets us guarantee a consistent, reproducible product. Smaller requests can sometimes seem attractive, but miniature batches expose operators and labs to disproportionately high costs for things like solvent handling, purification, and waste management.
Packaging also plays a role. Custom or non-standard packaging for sub-MOQ quantities adds complexity, potentially delaying timeline commitments and introducing unnecessary risks to product integrity. Larger order volumes let us keep pricing competitive, ensure stability during transit, and streamline documentation.
Lead time for Acetoacet-p-phenetidide begins once technical and commercial expectations are clear—grade, packaging, and required supporting documents such as COAs. Raw material sourcing, batch slot assignment, and reactor availability all influence our production roadmap. Sourcing starting materials is not always instant, so our planning team builds in buffer days for incoming supplies and ensures regulatory checks are completed in parallel. Our standard lead time falls within a range determined by current capacity and demand trends across the season. For recurring business or projected schedules, we block production windows in advance, granting buyers predictable shipment dispatch and reducing days lost to waiting lists.
Unexpected surges in orders—especially in the fine chemicals and pharmaceutical intermediates sectors—push demand into peaks that stretch standard lead times. By investing in flexible reactor trains and doubling critical inventory at our warehouses, we insulate recurring customers from the bump in turnaround time. For larger or ongoing contracts, we align production cycles with customers’ annual planning calendars and lock in delivery slots, turning lead time from a moving target into a managed promise.
Setting MOQs and communicating realistic lead times serves both the buyer and the producer. Too low an MOQ undermines batch consistency, risks contamination, and generates unnecessary waste. Unrealistic lead-time promises erode trust and harm production planning across every business down the chain. By holding firm to proven guidelines, we foster reliability for both sides of the transaction.
Our teams track persistent shifts in global logistics, anticipate raw material volatility, and adapt batch sizes and sequencing as needs evolve. We provide detailed order tracking and transparency from synthesis to dispatch. If you require technical documentation or want to align forecasted usage with our production cycles, our technical team provides tailored guidance based on decades of plant operation and customer support.
At the core, real-world MOQ and lead-time policies reflect a lived balance: safe, efficient manufacture meets responsible business delivery, supporting project execution from lab bench to final formulation.
Shipping Acetoacet-p-phenetidide crosses the threshold from routine logistics into a specialized operation influenced by both chemistry and regulation. As manufacturers, our factory team handles these challenges daily, coordinating production, packaging, and export to meet expectations set by both business and law in every market we serve.
Direct from the manufacturing floor, our batches of Acetoacet-p-phenetidide travel in tightly-sealed, chemical-resistant containers designed to prevent leaks, absorption, or cross-contamination. We do not rely on generic drums or off-the-shelf packaging. Over time, our engineers have selected materials proven to minimize vapor transmission, resist physical stress during multi-mode shipping, and withstand environmental changes from warehouse to port to final destination. Every outgoing shipment receives thorough lot traceability, and detailed labeling in accordance with current rules—UN numbers, hazard symbols, and language compliant with GHS requirements appear clearly on each unit, supporting fast customs clearance and regulatory audits.
Bulk cartons or customized packaging formats are available based on receiving country preference and transit length. Sea freight remains the standard, supported by temperature monitoring and handling protocols matched to the product’s thermal sensitivity and chemical profile. Our experience shows that well-prepared documentation, combined with clear hazard communication, streamlines international transit and reduces the risk of shipment detention or return. Coordination with freight partners allows our team to minimize vibration and shock exposure, as Acetoacet-p-phenetidide’s stability depends in part on these transportation variables. Air freight gets additional attention, especially regarding pressurization and rapid temperature changes, for emergency supply scenarios or short-lead custom lots.
Our regulatory team tracks updates on chemical control lists, particularly the frameworks managed by authorities in North America, the EU, and Asia-Pacific regions. Before offering Acetoacet-p-phenetidide for export, we verify registration status, local pre-notification, and necessary permits for classification under international conventions such as REACH, TSCA, and the IMDG Code. This documentation is matched to the batch’s chain of custody, so customers receive paperwork and certifications that reflect the actual manufacturing process and batch controls—not theoretical or generic documentation. We do not ship material into markets where legal status is unclear or contested, and we publish any current import country restrictions directly to our clients before confirming an order.
At the production site, staff receive targeted training based on current best practices for containment, personal protective equipment, and spill response. Vendor audits on all raw materials, as well as outgoing QA on product stability, feed a feedback loop to improve both product safety and downstream compliance. International transit expands these responsibilities: for countries requiring additional disclosures or safety measures, we supply MSDS in local languages and coordinate with destination warehouse teams to verify readiness to receive and store materials safely upon arrival.
Compliance and logistics expectations keep evolving. Our technical experts run risk assessments for all new logistics routes or regulations. Customers working on custom projects or unusual supply chain needs can expect detailed answers—drawn from real-world shipping reports and regulatory logs, not generic statements. We maintain a global database of compliance cases related to Acetoacet-p-phenetidide, supporting rapid adaptation if destination countries tighten requirements unexpectedly. Our goal is to keep production timelines on track, reduce customs clearance risks, and eliminate preventable supply chain failures tied to regulatory compliance gaps.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725